Showing posts with label children. Show all posts
Showing posts with label children. Show all posts

Tuesday, January 13, 2009

Vicks VapoRub Harmful to Kids

Cold ointments may spell serious breathing problems for children

As far as home remedies go, it's right up there with chicken noodle soup. But parents who use Vicks VapoRub to help their children get over a cold may, in some instances, do more harm than good.

A new study published today in the journal Chest warns that putting the mentholated ointment under or in a child's nostrils can prompt mucus production and cause serious breathing problems.

"I think it will surprise some folks because it is used this way," said Bruce Rubin, professor and vice-chairman for research in the pediatrics department at the Wake Forest University School of Medicine in North Carolina and lead author of the study.

Although health professionals and product manufacturers have long known that using Vicks VapoRub and similar generic products on children can present risks, many parents may not be getting that message, Dr. Rubin said.

"I think most people aren't aware of [the risks] and I think most people don't read the warning label," he said.

The label on Vicks VapoRub, for instance, advises parents to consult a physician before using the product on children under age 2. A warning also states that the product shouldn't be rubbed in the nostril.

But the study said many parents or caregivers may miss, or even ignore, this warning, not realizing the harmful effects the product can have on very young children.

Dr. Rubin and his colleagues embarked on the study after taking care of an 18-month-old girl who was brought to the hospital with severe breathing problems. Doctors couldn't figure out what had caused the girl, who was suffering from a cold and hadn't been given any medication, to suddenly experience "severe respiratory distress."

After asking the child's grandparents to think of anything they may have done before she began to have trouble breathing, her grandmother said she had put Vicks under her nostrils less than an hour before.

After the child recovered, doctors at the hospital began to routinely ask about the use of mentholated ointments and found several cases were similar.

Researchers then began a study using ferrets, which have a similar airway to humans, to determine what could be causing the problem among young children. They found that Vicks VapoRub causes an increase in mucus, which can lead to serious problems among children. A child's airway is tightened and narrowed by a virus, and thus a significant increase in mucus can lead to serious breathing difficulties like those noted by Dr. Rubin and his colleagues.

That's not to say mentholated ointments don't provide relief. In adults, they deliver a cool sensation that tricks the brain into thinking airflow is increasing. In reality, the preparations don't act as a decongestant or help a person to breathe better. But they do make a person feel like they can breathe better, helping them feel more comfortable as they fight a cold.

The warning about the menthol-based ointment is particularly timely, considering health officials are moving to restrict the use of over-the-counter medications in children.

Last month, Health Canada warned that cough and cold medications shouldn't be given to children under 6 because there isn't enough information to prove they're effective. These medications were linked to some health problems among children in Canada in recent years, including five deaths.

It's possible the new restrictions on cold medications may prompt some parents to look more closely at alternative or home remedies to help their children. If that's the case, parents must understand that over-the-counter remedies that are used safely in adults could cause serious problems in kids.

"You need to be aware that unless these are studied in children, there might be unrecognized risks," Dr. Rubin said.

A Canadian pediatrician agreed that parents should be wary of giving children over-the-counter cold remedies, even if they're considered to be natural.

"A lot of the natural products on the market have not been tested," said Danielle Grenier, medical affairs director at the Canadian Paediatric Society. "Even if it's a natural product, it still has ingredients. We know that it can have side effects."

The best advice she has for parents is to rely on the simplest solutions to help your child through a cold: plenty of warm liquids and a lot of rest.

"They're still the best," Dr. Grenier said.


Source: TheGlobeandMail.ca

Thursday, July 3, 2008

ADHD Drug Linked to Suicide

ADHD drug linked to suicide attempts: Health Canada


A drug commonly used to treat attention-deficit hyperactivity (ADHD) disorder in children, teens and adults has been linked to numerous adverse reactions, including suicide attempts, Health Canada has warned.

In its adverse reactions newsletter from July 2008, the health agency warns that Atomoxetine (Strattera), a selective norepinephrine reuptake inhibitor, had been linked to 189 reported adverse reactions as of Dec. 31, 2007.

Fifty-five of those included suicide attempts, a designation that encompasses non-accidental overdoses, showing suicidal tendencies and experiencing thoughts of self-harm. Twenty-nine of the patients recovered, three had not by Dec. 31, 2007, and one patient died. Data was not available for the remaining 22 patients.

Among the 55 suicide attempts reported in connection with the drug, 43 were among children between the ages of 6 and 17. Twelve were among adults ranging in age from 18 to 45.

Links between the drug and suicidal behaviour were first reported in September 2005, and the warnings and precautions section of the drug's monograph was changed to reflect those concerns.

Health Canada advises health-care professionals to warn patients who are on ADHD medications, as well as their families and other caregivers, to be on the lookout for changes in mood, behaviour and feelings.
Source: CBC.ca

Thursday, June 5, 2008

Dental Fillings Pose Risk - FDA

Mercury fillings pose health risks, FDA warns


Mercury in dental amalgams may pose health risks to children, fetuses and pregnant women, the U.S. Food and Drug Administration is warning.

The FDA issued a statement, on its website Wednesday, about the potential dangers of dental amalgams.

As part of a legal settlement reached Monday, the federal agency has agreed to release a new ruling on the safety of dental amalgams in July 2009, and alert consumers about potential related hazards. Consumer advocacy groups, including Moms Against Mercury, called for a ban on the fillings in the U.S.

"Dental amalgams contain mercury, which may have neurotoxic effects on the nervous systems of developing children and fetuses," the FDA said.

"When amalgam fillings are placed in teeth or removed from teeth, they release mercury vapour. Mercury vapour is also released during chewing."

The FDA says consumers should not have amalgam fillings removed.

Health Canada says that while amalgam has been shown to release mercury in the body, the levels are not serious enough to cause adverse health effects.

The federal agency says current data does not support hypotheses linking mercury exposure with Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis and Parkinson's disease.

But the federal agency notes patients with kidney disease and pregnant women should avoid dental amalgams given that mercury has been shown to cross the placental barrier and weaken kidney function at sub-clinical levels of exposure.

Sweden and Norway have banned the use of dental amalgams, citing health concerns.

Source: CBC.ca

Wednesday, June 4, 2008

Ontario KingFisher Cantaloupe Recall - Potential Salmonella

The Canadian Food Inspection Agency is warning the public not to consume some KingFisher brand cantaloupes because they may be contaminated with salmonella.

The affected produce was distributed in cartons of six or nine cantaloupes and bears stickers with the following information:

KingFisher Brand

Produce of U.S.A.

UPC 0 33383 11600 6

4050

Fisher Ranch Corp., Blythe, CA, 92225

These cantaloupes were distributed in Ontario and sold between May 16 and June 2.
Consumers who have purchased whole cantaloupes or in-store products containing pieces of fresh cantaloupes and are not sure of the brand should inquire at the place of purchase to verify if the stores have received the affected product.

There have been no reported illnesses associated with the consumption of the affected cantaloupes.

Consumption of food contaminated with this bacteria may cause salmonellosis.

In young children, the elderly and people with weakened immune systems, salmonellosis may cause serious and sometimes deadly infections.

In otherwise healthy people, salmonellosis may cause short-term symptoms such as high fever, severe headache, vomiting, nausea, abdominal pain and diarrhea.

The importer, Gambles Ontario Produce Inc. of Toronto, is voluntarily recalling the affected cantaloupes from the marketplace.

The CFIA is monitoring the effectiveness of the recall.

Source: Canadian Press

Saturday, March 3, 2007

Children's Cold Medicine Investigation

U.S. investigating children's cold medicines: report

Common children's cold and cough medicines are coming under scrutiny from U.S. federal drug regulators, who say the remedies and their recommended doses have not been studied enough in children, the New York Times reported Friday.

Dr. Charles J. Ganley, a top Food and Drug Administration official, said the agency was "revisiting the risks and benefits of the use of these drugs in children," especially those younger than two years old, the paper reported.

Most over-the-counter cold and cough medicines have been insufficiently tested in children, said Ganley, the director of the FDA's office of non-prescription drug products.

"We have no data on these agents of what's a safe and effective dose in children," he told the Times in an interview.

The FDA said it could not yet determine whether new regulations would result from the safety review, according to the newspaper.

A group of pediatricians and public health officials asked the agency Thursday to bar drug manufacturers from marketing remedies such as Toddler's Dimetapp, Infant Triaminic and Little Colds to children under six.

Cold medicines killed 3 children: study

A recent study by the U.S. Centers for Disease Control and Prevention showed that in 2004 and 2005, more than 1,500 children under two had experienced serious health problems — and three died — after taking common cold medicines.

The American College of Chest Physicians last year recommended avoiding giving cough and cold medicines to children, especially young ones.

In above-normal doses, cold medicines can lead to heart arrhythmias, and some have been linked to hypertension and stroke when taken in high doses, the Times reported.

In rare cases, children have had medical problems after taking recommended doses, the article said.

The president of the Consumer Healthcare Products Association, which represents companies that sell over-the-counter cold drugs, noted that the medicines had FDA approval and had been used for decades. They should be taken only in recommended doses, association president Linda A. Suydam said.

The pediatricians who petitioned the FDA Thursday acknowledged that children's cold medicines were generally safe in recommended doses, but they said overdoses were common because many children were given more than one medicine, among other reasons.

They also questioned the drugs' effectiveness in children.

Many cold and cough drugs won FDA approval decades ago, when the agency's standards were less strict, the Times reported.

Source: CBC.ca